Solubility & Bioavailability: Difficult Beasts to Tame – Quotient Sciences Dr. Dolly Jacob, Director of Integrated Development Services speaks with Drug Development & Delivery
Poor solubility is becoming increasingly prevalent in drug pipelines. Infact, across the pharmaceutical industry, about 70 percent of drugs that enter development possess insufficient aqueous solubility for adequate and consistent gastrointestinal absorption.
In a recent article with Drug Development & Delivery, Quotient Sciences, Dr. Jacob discussed how the industries solubility and bioavailability challenges increase formulation complexity, raise failure rates, and drive-up development costs. At Quotient Sciences we find solutions to unlocking the potential of each small molecule we work with.
Read more:
External URL: https://www.quotientsciences.com/news/dr-dolly-jacob-solubility-bioavailability-challenge/
By Arcinova
262 Views
Recent Posts
- Hazardous waste incinerator reopens in the North East
- NEPIC are hiring!
- Score Group New Brand!
- Teesside-Based IAMTech Teams Up with Operation Smile UK for Transformative Efforts During National Smile Month
- Boosting chemical production efficiency with clamp-on ultrasonic flow measurement
Back to News >
Share this
© Copyright. North East of England Process Industry Cluster (NEPIC) 2015
Built by iTCHYROBOT